Location History:
- East York, CA (2004 - 2006)
- Toronto, CA (2013)
Company Filing History:
Years Active: 2004-2013
Title: Innovations by Andrew R Crow in Autoimmune Disease Treatment
Introduction
Andrew R Crow is a notable inventor based in Toronto, Canada, recognized for his contributions to the field of medical therapies, particularly in treating autoimmune diseases. With a total of three patents to his name, Crow has made significant strides in developing innovative methods that aim to improve patient outcomes.
Latest Patents
Among his latest patents is a groundbreaking method for treating autoimmune diseases and compositions therefor. This method involves a cell-based therapy designed to stimulate leukocytes and/or dendritic cells to interrupt autoimmunity in a host. The approach utilizes a Fcγ receptor-specific complex or a complex that facilitates the co-crosslinking of Fcγ-chains to treat the leukocytes and/or dendritic cells. Upon reintroducing the pre-treated biological sample to the patient, the dendritic cells elicit an autoimmune interruption response in vivo. Another significant patent focuses on methods of inhibiting platelet anti-HLA alloimmune antibody responses using a soluble 18 KDa CD40L. This invention aims to inhibit an in vivo alloimmune response through the use of a soluble recombinant human CD40L protein that contains the active binding site with CD40.
Career Highlights
Andrew R Crow is currently affiliated with Canadian Blood Services, where he applies his expertise in immunology and therapeutic development. His work is pivotal in advancing the understanding and treatment of autoimmune conditions, which affect millions of individuals